November 2024 – Clinical Protocol Finalized for Phase III

Adapet’s medical and scientific teams finalized the standard operating procedures (SOPs) and data frameworks for the upcoming Phase III clinical trial. This included protocols for multi-center testing, data anonymization, baseline condition stratification, and BGM-to-CGM comparison metrics. The structured approach allows integration with academic institutions and ensures the clinical data aligns with global standards for peer-reviewed publication and potential inclusion in professional guidelines.